Background Image
Table of Contents Table of Contents
Previous Page  68 / 68
Information
Show Menu
Previous Page 68 / 68
Page Background

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

Carzin XL.

Each film coated tablet contains 4 mg doxazosin. Reg. No.: RSA S3 41/7.1/0557. NAM NS2 10/34/0376. For full prescribing information, refer to the package insert approved by the Medicines Control Council, July 2009.

1)

Pompeo ACL,

et al.

A randomised, double blind study comparing the efficacy and tolerability of controlled release Doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia. Int J. Clin Pract Oct 2006;60(10):1172-

1177.

2)

Kirby RS,

et al.

A Combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. British

Journal of Urology International 2001 Feb;87(3):192-200.

3)

Carzin XL package insert.

4)

Vs. Doxazosin XL originator 4 mg modified release formulation. Department of Health website

. http://www.mpr.gov.za

- Accessed 21/05/2015.

CLXC73/01/2015

DOXAZOSIN 4 mg

onset for

consistent flow

1

Slower

A

slower

onset of action vs IR formulations to allow

fewer titration steps and to minimize side-e‹ects

2

.

Eective

treatment for urinary outflow obstruction

and BPH symptoms

3

.

Safe

BPH treatment for normotensive and

hypertensive patients

3

.

Carzin XL

, the extended release doxazosin o‹ers:

SAVING

4

%

50

MORE THAN

A Lupin Group Company

Printed by Tandym Printers